Clinical Trials
-
Principal Investigator:
Prakash Satwani, MDThe COVID-19 Hematology, Oncology, Stem Cell Transplant (HOT) Consortium of Greater New York City is trying to learn more about the effects of COVID-19 on hemoglobinopathies, immunodeficiencies and cancer in children and young adults. Although exact studies for which the Research Database data may be used are not known at this time, the following are types of studies in which these data may be included are: 1) Studies to determine how well people recover from a COVID-19 infection, 2) Studies on how recovery after COVID-19 can be improved, 3) Studies to look at how various demographic and... -
Principal Investigator:
Wendy K. Chung, MD, PhDEach year more than 1,000 babies in the United States are born with a Congential Diaphragmatic Hernia (CDH). For the majority of these babies, the cause of the CDH is unknown. DHREAMS (Diaphragmatic Hernia Research & Exploration; Advancing Molecular Science) study was created to improve the understanding of the molecular genetic basis of CDH. This National Institute of Health (NIH)-funded research team is composed of health care providers and researchers across the country, coordinated at Columbia University Medical Center. Multiple medical centers are enrolling individuals and families... -
Principal Investigator:
Rakesh Sahni, MBBSThe purpose of this study is to see if the use of bubble nasal continuous positive airway pressure (NCPAP) at a pressure of 6-7 centimeters of water (cm H2O) in very low birth weight (VLBW) infants is associated with improved gas exchange without any related changes in vital signs. -
Principal Investigator:
Stephanie Levasseur, MDAlthough supraventricular tachycardia (SVT), including atrial flutter (AF), are the most common causes of intended in-utero fetal therapy, none of the medication used to date has been evaluated for their effects on the mother and her baby in a randomized controlled clinical trial (RCT). In the absence of such evidence, there is no consensus for the optimal management. The purpose of the FAST Research study is to improve the care of pregnancies affected by AF or SVT. The aim of the FAST Registry is to record the treatment your doctor prescribes, your ongoing care, and the outcome of your... -
Principal Investigator:
Stephanie Levasseur, MDThe purpose of the study is to clarify the best treatment for your babys condition by looking at how well the medicine worked to bring your babys heart rate back to normal and if you experienced any side-effects from the treatment. You are being asked to take part in a research study because your fetus has been diagnosed with a fast heart rate. Although supraventricular tachycardia (SVT), including atrial flutter (AF), are the most common causes of intended in-utero fetal therapy, none of the medication used to date has been evaluated for their effects on the mother and her baby in a... -
Principal Investigator:
Wendy K. Chung, MD, PhDThis study is designed to determine the role of specific genes in obesity and/or type 2 diabetes mellitus. Patients who are severely obese, and/or with an onset of type 2 diabetes at less than 25 years of age. Ideally, we would like to have families involved in this study. The ideal family is one in which NOT everyone in the family is obese or diabetic. Families in which one or neither parent is obese/diabetic, and some but not all children are obese/diabetic, are ideal. -
Principal Investigator:
Wendy K. Chung, MD, PhDThe goal of this study is to better understand the genetic causes of weight gain. Your participation will help us understand how why some people gain more weight and why others do not.We will ask you questions about your weight and your height to determine if you are eligible. If you are eligible, we will invite you to participate. To participate, we will ask you questions about your medical history and eating habits and ask you to provide a blood or saliva sample for genetic testing. We will test the DNA from your blood or saliva sample to try to identify if you have a genetic cause for your... -
Principal Investigator:
Vidhu Thaker, MDWe will enroll children with severe early onset obesity (BMI - 99th percentile) diagnosed prior to 6 years of age. We will ask questions about their health, eating behavior and perform a brief physical examination. We will collect saliva or blood to perform genetic testing. We will also invite family members to participate in the genetic study. -
Principal Investigator:
Cindy Elizabeth Neunert, MDThe purpose of this study is investigate the safety and effectiveness of eltrombopag (investigational drug) in treating children and adolescents with newly-diagnosed immune thrombocytopenia (ITP), which is a rare blood disorder. -
Principal Investigator:
Vidhu Thaker, MDWe are interested in studying the health of you and your family. Our study involves completing an online survey about your and your family's health and behaviors, and giving us access to basic health information that includes you and your child's vitals, weight/height, and BMI. You can receive up to $25 in Amazon pay cards for your participation. Spanish/English speakers who have a child 5 - 12 years of age are eligible to participate.